PRICE T ROWE ASSOCIATES INC /MD/ - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$90,400,000
-0.3%
5,518,932
+2.5%
0.01%
+12.5%
Q2 2021$90,651,000
-8.7%
5,386,303
-0.9%
0.01%
-20.0%
Q1 2021$99,278,000
+1.7%
5,436,898
+1.4%
0.01%0.0%
Q4 2020$97,600,000
+1.6%
5,362,644
-0.4%
0.01%
-9.1%
Q3 2020$96,043,000
-2.5%
5,383,566
-2.0%
0.01%
-8.3%
Q2 2020$98,531,000
+16.6%
5,495,336
-1.3%
0.01%
-7.7%
Q1 2020$84,514,000
+4.2%
5,567,466
+35.5%
0.01%
+18.2%
Q4 2019$81,078,000
+13.4%
4,109,398
-1.1%
0.01%
+10.0%
Q3 2019$71,490,000
-3.3%
4,156,367
-0.5%
0.01%0.0%
Q2 2019$73,913,000
-39.1%
4,175,898
-29.9%
0.01%
-44.4%
Q1 2019$121,336,0005,956,5970.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders